123 related articles for article (PubMed ID: 35797892)
1. In vitro characterization and molecular dynamic simulation of shikonin as a tubulin-targeted anticancer agent.
Radha G; Naik PK; Lopus M
Comput Biol Med; 2022 Aug; 147():105789. PubMed ID: 35797892
[TBL] [Abstract][Full Text] [Related]
2. A potent anticancer agent of shikonin derivative targeting tubulin.
Baloch SK; Ma L; Xu GH; Bai LF; Zhao H; Tang CY; Pang YJ; Yang RW; Wang XM; Lu GH; Yang YH
Chirality; 2015 Mar; 27(3):274-80. PubMed ID: 25663187
[TBL] [Abstract][Full Text] [Related]
3. Novel shikonin derivatives targeting tubulin as anticancer agents.
Guo J; Chen XF; Liu J; Lin HY; Han HW; Liu HC; Huang SC; Shahla BK; Kulek A; Qi JL; Wang XM; Ling LJ; Yang YH
Chem Biol Drug Des; 2014 Nov; 84(5):603-15. PubMed ID: 24797889
[TBL] [Abstract][Full Text] [Related]
4. Rational design of biaryl pharmacophore inserted noscapine derivatives as potent tubulin binding anticancer agents.
Santoshi S; Manchukonda NK; Suri C; Sharma M; Sridhar B; Joseph S; Lopus M; Kantevari S; Baitharu I; Naik PK
J Comput Aided Mol Des; 2015 Mar; 29(3):249-70. PubMed ID: 25481458
[TBL] [Abstract][Full Text] [Related]
5. Griseofulvin stabilizes microtubule dynamics, activates p53 and inhibits the proliferation of MCF-7 cells synergistically with vinblastine.
Rathinasamy K; Jindal B; Asthana J; Singh P; Balaji PV; Panda D
BMC Cancer; 2010 May; 10():213. PubMed ID: 20482847
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of heterocyclic carboxylic acyl shikonin derivatives.
Wang XM; Lin HY; Kong WY; Guo J; Shi J; Huang SC; Qi JL; Yang RW; Gu HW; Yang YH
Chem Biol Drug Des; 2014 Mar; 83(3):334-43. PubMed ID: 24118825
[TBL] [Abstract][Full Text] [Related]
7. The natural naphthoquinone plumbagin exhibits antiproliferative activity and disrupts the microtubule network through tubulin binding.
Acharya BR; Bhattacharyya B; Chakrabarti G
Biochemistry; 2008 Jul; 47(30):7838-45. PubMed ID: 18597479
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative efficacy and mechanism of action of garlic phytochemicals-functionalized gold nanoparticles in triple-negative breast cancer cells.
Meher K; Paithankar H; Hosur RV; Lopus M
Biomed Mater; 2024 Apr; 19(3):. PubMed ID: 38682577
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel microtubule stabilizers targeting taxane binding site by applying molecular docking, molecular dynamics simulation, and anticancer activity testing.
Zhang H; Qi HZ; Mao J; Zhang HR; Luo QQ; Hu ML; Shen C; Ding L
Bioorg Chem; 2022 May; 122():105722. PubMed ID: 35303622
[TBL] [Abstract][Full Text] [Related]
10. Anticancer mechanism of 7-α-hydroxyfrullanolide on microtubules and computational prediction of its target binding in triple-negative breast cancer cells.
Chimplee S; Smythe C; Tipmanee V; Sukrong S; Kanokwiroon K
PeerJ; 2022; 10():e13508. PubMed ID: 35651747
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and Preclinical Evaluation of Indole Triazole Conjugates as Microtubule Targeting Agents that are Effective against MCF-7 Breast Cancer Cell Lines.
Yele V; Pindiprolu SKSS; Sana S; Ramamurty DSVNM; Madasi JRK; Vadlamani S
Anticancer Agents Med Chem; 2021; 21(8):1047-1055. PubMed ID: 32981511
[TBL] [Abstract][Full Text] [Related]
12. Discovery of microtubule stabilizers with novel scaffold structures based on virtual screening, biological evaluation, and molecular dynamics simulation.
Mao J; Luo QQ; Zhang HR; Zheng XH; Shen C; Qi HZ; Hu ML; Zhang H
Chem Biol Interact; 2022 Jan; 352():109784. PubMed ID: 34932952
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel shikonin-benzo[b]furan derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
Shao YY; Yin Y; Lian BP; Leng JF; Xia YZ; Kong LY
Eur J Med Chem; 2020 Mar; 190():112105. PubMed ID: 32035399
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization.
Lin HY; Li ZK; Bai LF; Baloch SK; Wang F; Qiu HY; Wang X; Qi JL; Yang RW; Wang XM; Yang YH
Biochem Pharmacol; 2015 Jul; 96(2):93-106. PubMed ID: 25957661
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of benzoylacrylic acid shikonin ester derivatives as irreversible dual inhibitors of tubulin and EGFR.
Sun WX; Han HW; Yang MK; Wen ZL; Wang YS; Fu JY; Lu YT; Wang MY; Bao JX; Lu GH; Qi JL; Wang XM; Lin HY; Yang YH
Bioorg Med Chem; 2019 Dec; 27(23):115153. PubMed ID: 31648877
[TBL] [Abstract][Full Text] [Related]
16. Indicine N-oxide binds to tubulin at a distinct site and inhibits the assembly of microtubules: a mechanism for its cytotoxic activity.
Appadurai P; Rathinasamy K
Toxicol Lett; 2014 Feb; 225(1):66-77. PubMed ID: 24300171
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Biological Evaluation of 2-Substituted Benzyl-/Phenylethylamino-4-amino-5-aroylthiazoles as Apoptosis-Inducing Anticancer Agents.
Oliva P; Onnis V; Balboni E; Hamel E; Estévez-Sarmiento F; Quintana J; Estévez F; Brancale A; Ferla S; Manfredini S; Romagnoli R
Molecules; 2020 May; 25(9):. PubMed ID: 32384805
[TBL] [Abstract][Full Text] [Related]
18. Aqueous extract of Triphala inhibits cancer cell proliferation through perturbation of microtubule assembly dynamics.
Cheriyamundath S; Mahaddalkar T; Save SN; Choudhary S; Hosur RV; Lopus M
Biomed Pharmacother; 2018 Feb; 98():76-81. PubMed ID: 29245069
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization and molecular dynamic simulation of β-sitosterol as a tubulin-binding anticancer agent.
Mahaddalkar T; Suri C; Naik PK; Lopus M
Eur J Pharmacol; 2015 Aug; 760():154-62. PubMed ID: 25912799
[TBL] [Abstract][Full Text] [Related]
20. Tubulin- and ROS-dependent antiproliferative mechanism of a potent analogue of noscapine, N-propargyl noscapine.
Nambiar N; Nagireddy PKR; Pedapati R; Kantevari S; Lopus M
Life Sci; 2020 Oct; 258():118238. PubMed ID: 32791146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
